Cargando…

Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding

Pregnant patients with short bowel syndrome (SBS) and chronic intestinal failure (CIF) can successfully reach to term their pregnancies while on parenteral nutrition (PN) but with high rates of complications. The combination of rehabilitation surgery, combined with the use of novel treatment with en...

Descripción completa

Detalles Bibliográficos
Autores principales: MV, Gentilini, M, Doeyo, M, Ortega, L, Illidge Perez, C, Rumbo, PC, Arriola Benitez, A, Crivelli, M, Rumbo, H, Solar, GE, Gondolesi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706046/
https://www.ncbi.nlm.nih.gov/pubmed/36458051
http://dx.doi.org/10.1177/17562848221129787
_version_ 1784840422918455296
author MV, Gentilini
M, Doeyo
M, Ortega
L, Illidge Perez
C, Rumbo
PC, Arriola Benitez
A, Crivelli
M, Rumbo
H, Solar
GE, Gondolesi
author_facet MV, Gentilini
M, Doeyo
M, Ortega
L, Illidge Perez
C, Rumbo
PC, Arriola Benitez
A, Crivelli
M, Rumbo
H, Solar
GE, Gondolesi
author_sort MV, Gentilini
collection PubMed
description Pregnant patients with short bowel syndrome (SBS) and chronic intestinal failure (CIF) can successfully reach to term their pregnancies while on parenteral nutrition (PN) but with high rates of complications. The combination of rehabilitation surgery, combined with the use of novel treatment with enterohormones, especially semisynthetic glucagon-like peptide 2 (sGLP-2), has increased the chances to achieve intestinal sufficiency. Here, we report the case of a 33-year-old female with SBS/CIF (anatomy type 2), weaned off PN using sGLP-2 for 3.7 years, discontinued when she became pregnant. She was able to carry the pregnancy to term without any additional PN support. Considering that, we queried if the endogenous GLP-2 (eGLP-2) levels in this SBS patient, during the pregnancy and breastfeeding period, could be like those presented in healthy pregnant women and in non-pregnant SBS patients. Also, we inquired if there was any passage or increase in the plasmatic eGLP-2 from the fetus to the mother. Thus, we determined eGLP-2 levels in paired neonatal (cord blood) and maternal plasma samples from the SBS pregnant patient (n = 1), healthy pregnant women (controls, n = 2), and non-pregnant SBS patients (n = 12). The results indicated that the SBS pregnant patient showed higher eGLP-2 levels than non-SBS pregnant patients and healthy pregnant women along all the period studied. Furthermore, we found that the maternal sample had higher eGLP-2 levels than the neonatal sample, suggesting that fetal contribution to maternal eGLP2 levels would be minor. In conclusion, this study not only reports for the first time a case of a patient with SBS that was able to achieve intestinal adaptation after combining the use of autologous reconstructive surgery and sGLP-2, but also enlightens the possibility of carrying out an uneventful pregnancy and lactation without any nutritional support and remaining independent of sGLP-2.
format Online
Article
Text
id pubmed-9706046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97060462022-11-30 Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding MV, Gentilini M, Doeyo M, Ortega L, Illidge Perez C, Rumbo PC, Arriola Benitez A, Crivelli M, Rumbo H, Solar GE, Gondolesi Therap Adv Gastroenterol Case Report Pregnant patients with short bowel syndrome (SBS) and chronic intestinal failure (CIF) can successfully reach to term their pregnancies while on parenteral nutrition (PN) but with high rates of complications. The combination of rehabilitation surgery, combined with the use of novel treatment with enterohormones, especially semisynthetic glucagon-like peptide 2 (sGLP-2), has increased the chances to achieve intestinal sufficiency. Here, we report the case of a 33-year-old female with SBS/CIF (anatomy type 2), weaned off PN using sGLP-2 for 3.7 years, discontinued when she became pregnant. She was able to carry the pregnancy to term without any additional PN support. Considering that, we queried if the endogenous GLP-2 (eGLP-2) levels in this SBS patient, during the pregnancy and breastfeeding period, could be like those presented in healthy pregnant women and in non-pregnant SBS patients. Also, we inquired if there was any passage or increase in the plasmatic eGLP-2 from the fetus to the mother. Thus, we determined eGLP-2 levels in paired neonatal (cord blood) and maternal plasma samples from the SBS pregnant patient (n = 1), healthy pregnant women (controls, n = 2), and non-pregnant SBS patients (n = 12). The results indicated that the SBS pregnant patient showed higher eGLP-2 levels than non-SBS pregnant patients and healthy pregnant women along all the period studied. Furthermore, we found that the maternal sample had higher eGLP-2 levels than the neonatal sample, suggesting that fetal contribution to maternal eGLP2 levels would be minor. In conclusion, this study not only reports for the first time a case of a patient with SBS that was able to achieve intestinal adaptation after combining the use of autologous reconstructive surgery and sGLP-2, but also enlightens the possibility of carrying out an uneventful pregnancy and lactation without any nutritional support and remaining independent of sGLP-2. SAGE Publications 2022-11-22 /pmc/articles/PMC9706046/ /pubmed/36458051 http://dx.doi.org/10.1177/17562848221129787 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
MV, Gentilini
M, Doeyo
M, Ortega
L, Illidge Perez
C, Rumbo
PC, Arriola Benitez
A, Crivelli
M, Rumbo
H, Solar
GE, Gondolesi
Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title_full Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title_fullStr Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title_full_unstemmed Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title_short Successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sGLP-2 treatment: novel report on endogenous GLP-2 levels at delivery and during breastfeeding
title_sort successful pregnancy in a patient with short bowel syndrome after surgical rehabilitation and sglp-2 treatment: novel report on endogenous glp-2 levels at delivery and during breastfeeding
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706046/
https://www.ncbi.nlm.nih.gov/pubmed/36458051
http://dx.doi.org/10.1177/17562848221129787
work_keys_str_mv AT mvgentilini successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT mdoeyo successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT mortega successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT lillidgeperez successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT crumbo successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT pcarriolabenitez successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT acrivelli successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT mrumbo successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT hsolar successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding
AT gegondolesi successfulpregnancyinapatientwithshortbowelsyndromeaftersurgicalrehabilitationandsglp2treatmentnovelreportonendogenousglp2levelsatdeliveryandduringbreastfeeding